Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pediatric Cancers × Other neoplasm × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precancerous Conditions 135 Lymphoma 32 Leukemia 30 Multiple Myeloma 29 Neoplasms, Plasma Cell 28 Monoclonal Gammopathy of Undetermined Significance 27 Lymphoma, Non-Hodgkin 27 Lymphoma, Mantle-Cell 27 Lymphoma, Large-Cell, Immunoblastic 27 Lymphoma, Large B-Cell, Diffuse 27 Lymphoma, Follicular 27 Leukemia, Lymphocytic, Chronic, B-Cell 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Lymphoma, B-Cell, Marginal Zone 26 Burkitt Lymphoma 26 Immunoglobulin Light-chain Amyloidosis 25 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24 Myeloproliferative Disorders 24 Hodgkin Disease 24 Waldenstrom Macroglobulinemia 23 Immunoblastic Lymphadenopathy 23 Thrombocythemia, Essential 22 Primary Myelofibrosis 22 Myelodysplastic Syndromes 22 Lymphoma, Large-Cell, Anaplastic 22 Leukemia, Myeloid, Acute 22 Leukemia, Hairy Cell 22 Lymphoma, T-Cell, Cutaneous 21 Leukemia, Myeloid, Chronic-Phase 21 Leukemia, Large Granular Lymphocytic 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00575926 2007-12-18

Lingzhi for Cancer Children

Chinese University of Hong Kong

Phase 3 Completed

Pediatric Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡